Literature DB >> 3934967

Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.

J J Bending, J C Pickup, H Keen.   

Abstract

The frequency of diabetic ketoacidosis and hypoglycemic coma in a large series of patients with insulin-dependent diabetes treated by long-term continuous subcutaneous insulin infusion was compared with the frequency of these events in a matched group of patients treated by conventional insulin injections at the same hospital over the same period of time. Ketoacidosis and hypoglycemic coma occurred no more frequently in continuous subcutaneous insulin infusion-treated patients. Therefore, intensified insulin therapy achieved by continuous subcutaneous insulin infusion does not appear to be associated with a greater risk of ketoacidosis or hypoglycemic coma than does conventional insulin therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934967     DOI: 10.1016/0002-9343(85)90518-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Risks with continuous subcutaneous insulin infusion can be serious.

Authors:  G Knight
Journal:  BMJ       Date:  2001-09-22

2.  Continuous subcutaneous insulin infusion in type 1 diabetes.

Authors:  J Pickup; H Keen
Journal:  BMJ       Date:  2001-05-26

3.  Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.

Authors:  A J Scheen; J Gillet; J Rosenthaler; J Guiot; P Henrivaux; B Jandrain; P J Lefèbvre
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

Review 4.  [Insulin pump therapy in children, adolescents and adults].

Authors:  Marietta Stadler; Sandra Zlamal-Fortunat; Ingrid Schütz-Fuhrmann; Birgit Rami-Merhar; Elke Fröhlich-Reiterer; Sabine Hofer; Julia Mader; Michael Resl; Alexandra Kautzky-Willer; Raimund Weitgasser; Rudolf Prager; Martin Bischof
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

5.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.

Authors:  John Pickup; Martin Mattock; Sally Kerry
Journal:  BMJ       Date:  2002-03-23

6.  Severe hypoglycemia in insulin-dependent diabetic children treated by multiple injection insulin regimen.

Authors:  A Verrotti; F Chiarelli; A Blasetti; E Bruni; G Morgese
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

7.  Hyperkalaemia after interruption of CSII.

Authors:  J C Pickup
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

8.  Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.

Authors:  E Chantelau; M Spraul; I Mühlhauser; R Gause; M Berger
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

Review 9.  Quality of life and technology: impact on children and families with diabetes.

Authors:  Masakazu Hirose; Elizabeth A Beverly; Katie Weinger
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

10.  [Guidelines for insulin pump therapy in children and adults].

Authors:  Marietta Stadler; Sandra Zlamal-Fortunat; Ingrid Schütz-Fuhrmann; Birgit Rami-Merhar; Edith Schober; Alexandra Kautzky-Willer; Raimund Weitgasser; Rudolf Prager; Martin Bischof
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.